Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
46,993,886
-
Shares change
-
+1,978,063
-
Total reported value, excl. options
-
$848,220,501
-
Value change
-
+$35,391,534
-
Put/Call ratio
-
28%
-
Number of buys
-
49
-
Number of sells
-
-35
-
Price
-
$18.05
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2016
115 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q2 2016.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,993,886 shares
of 183,255,226 outstanding shares and own 25.64% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (7,752,460 shares), TANG CAPITAL MANAGEMENT LLC (6,197,198 shares), FMR LLC (5,493,420 shares), JANUS CAPITAL MANAGEMENT LLC (4,013,921 shares), Partner Fund Management, L.P. (3,351,104 shares), Invesco Ltd. (2,909,591 shares), BAKER BROS. ADVISORS LP (2,857,250 shares), Cormorant Asset Management, LLC (1,771,263 shares), Broadfin Capital, LLC (1,250,104 shares), and VANGUARD GROUP INC (1,215,343 shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.